SEC Form 4 · accession 0001144204-15-037647

Alliqua BioMedical, Inc. · ALQA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — See Remarks

Period of report

Jun 15, 2015

Accepted (ET)

Jun 17, 2015 · 4:06 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001054274

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jun 15, 2015	A	120,000	$0.00	A	120,000	D
Common Stock^F2	Jun 15, 2015	F	13,488	$5.25	D	106,512	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F3	$5.25	Jun 15, 2015	A	100,000	A	—	Jun 15, 2025	Common Stock	100,000	100,000	D

F1Represents a restricted stock award that is subject to forfeiture until vested. This award vests in four equal annual installments with one-quarter (1/4) vested on June 15, 2015 and one-quarter (1/4) vesting on each of June 15, 2016, 2017 and 2018, provided that Mr. Pionati is employed by or providing services to the Company through the applicable vesting date, subject to the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan (the "2014 Plan").
F2Represents shares of restricted stock withheld to pay Mr. Pionati's tax withholding obligations incurred in connection with the vesting of 30,000 shares of restricted stock on June 15, 2015.
F3The option vests in three equal annual installments, with one-third (1/3rd) vesting on each of June 15, 2016, 2017 and 2018, provided that Mr. Pionati is employed by or providing services to the Company through the applicable vesting date, subject to the terms and conditions of the 2014 Plan.

Chief Strategy and Marketing Officer